<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d34">
    <sentence id="DDI-DrugBank.d34.s0" text="Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy).">
        <entity charOffset="94-104" id="DDI-DrugBank.d34.s0.e0" text="dorzolamide" type="drug"/>
        <entity charOffset="155-183" id="DDI-DrugBank.d34.s0.e1" text="carbonic anhydrase inhibitors" type="group"/>
        <entity charOffset="286-295" id="DDI-DrugBank.d34.s0.e2" text="salicylate" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d34.s0.e0" e2="DDI-DrugBank.d34.s0.e1" id="DDI-DrugBank.d34.s0.p0" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d34.s0.e0" e2="DDI-DrugBank.d34.s0.e2" id="DDI-DrugBank.d34.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d34.s0.e1" e2="DDI-DrugBank.d34.s0.e2" id="DDI-DrugBank.d34.s0.p2"/>
    <negationtags>Although acid-base and electrolyte disturbances were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; reported in the clinical trials with dorzolamide, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d34.s1" text="Therefore, the potential for such drug interactions should be considered in patients receiving dorzolamide.">
        <entity charOffset="95-105" id="DDI-DrugBank.d34.s1.e0" text="dorzolamide" type="drug"/>
    </sentence>
</document>